Skip to content
MS
AGL AR unreviewed

Cori-Forbes disease (GSD III)

Enzyme or protein defect

Glycogen debranching enzyme

Accumulates or becomes deficient

Limit dextrin

Key features

Milder than GSD I; normal lactate, hepatomegaly, myopathy

Management

High-protein diet, frequent feeds

Not clinical guidance. Written from standard clinical biochemistry, not from the uploaded documents, and marked unreviewed. Teaching-level reference for study and database seeding only. It must not be used to manage a patient.

Recent literature

Europe PMC · from cache · sorted by publication date

  1. 1
    Cardiomyopathy in glycogen storage diseases: diagnosis, prognosis, and advanced management.

    Patel U, Gunes E, Chawla A, Ashman K, Taub A, Arakelyan T, Madani A, Patel K, Bui Q, Adler E. · 2026-07-10

    unreviewed
  2. 2
  3. 3
    Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment.

    Senarathne UD, Jasinge E, Viknarajah Mohan S, Waidyanatha S. · 2022-03-09

    cited 2× open access unreviewed
  4. 4
    251st ENMC international workshop: Polyglucosan storage myopathies 13-15 December 2019, Hoofddorp, the Netherlands.

    Laforêt P, Oldfors A, Malfatti E, Vissing J, ENMC 251st workshop study group. · 2021-01-23

    cited 6× unreviewed
  5. 5
    Biomarkers in Glycogen Storage Diseases: An Update.

    Molares-Vila A, Corbalán-Rivas A, Carnero-Gregorio M, González-Cespón JL, Rodríguez-Cerdeira C. · 2021-04-22

    cited 25× open access unreviewed
  6. 6
    Glycogen metabolism in humans.

    Adeva-Andany MM, González-Lucán M, Donapetry-García C, Fernández-Fernández C, Ameneiros-Rodríguez E. · 2016-02-27

    cited 339× open access unreviewed
  7. 7
    An insight into the biochemistry of inborn errors of metabolism for a clinical neurologist.

    Christopher R, Sankaran BP. · 2008-04-01

    cited 9× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.